| Year |
Title |
Altmetric |
| 2022
|
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms.
Nature Communications.
13.
2022
|
|
| 2022
|
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
2022
|
|
| 2021
|
Exploring human-genome gut-microbiome interaction in Parkinson’s disease.
npj Parkinson's Disease.
7.
2021
|
|
| 2021
|
Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease.
Annals of Neurology.
90:76-88.
2021
|
|
| 2021
|
Large-scale association analyses identify host factors influencing human gut microbiome composition.
Nature Genetics.
53:156-165.
2021
|
|
| 2020
|
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.
npj Parkinson's Disease.
6.
2020
|
|
| 2020
|
Large-scale association analyses identify host factors influencing human gut microbiome composition
2020
|
|
| 2020
|
Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens..
npj Parkinson's Disease.
6:11.
2020
|
|
| 2020
|
Characterizing dysbiosis of gut microbiome in PD: Evidence for overabundance of opportunistic pathogens
2020
|
|
| 2019
|
Using global team science to identify genetic parkinson's disease worldwide.
Annals of Neurology.
86:153-157.
2019
|
|
| 2018
|
Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease.
2018
|
|
| 2018
|
Meta-analysis of human genome-microbiome association studies: The MiBioGen consortium initiative.
Microbiome.
6.
2018
|
|
| 2018
|
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.
Movement Disorders.
33:793-804.
2018
|
|
| 2018
|
Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease.
Science Translational Medicine.
10.
2018
|
|
| 2017
|
The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.
Movement Disorders.
32:1139-1146.
2017
|
|
| 2017
|
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Movement Disorders.
32:739-749.
2017
|
|
| 2017
|
Caffeine, creatine, GRIN2A and Parkinson's disease progression.
Journal of the Neurological Sciences.
375:355-359.
2017
|
|
| 2016
|
Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.
Human Molecular Genetics.
25:3849-3862.
2016
|
|
| 2016
|
DNA variants in CACNA1C modify Parkinson disease risk only when Vitamin D level is deficient
2016
|
|
| 2015
|
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
Movement Disorders.
30:278-283.
2015
|
|
| 2014
|
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease..
Neurology.
83:1906-1913.
2014
|
|
| 2014
|
Erratum to "Exploratory analysis of seven Alzheimer's disease genes: Disease progression" [Neurobiol. Aging 34, (2013), 1310.e1-1310.e7], doi:10.1016/j.neurobiolaging.2012.08.014.
Neurobiology of Aging.
35:2661.
2014
|
|
| 2014
|
Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease.
PLoS Genetics.
10.
2014
|
|
| 2014
|
Identification of a novel Parkinson's disease locus via stratified genome-wide association study.
BMC Genomics.
15.
2014
|
|
| 2014
|
Cognitive and motor function in long-duration PARKIN-associated parkinson disease.
JAMA Neurology.
71:62-67.
2014
|
|
| 2014
|
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Nature Genetics.
46:989-993.
2014
|
|
| 2014
|
Promise of Pharmacogenomics for Drug Discovery, Treatment and Prevention of Parkinson's Disease. A Perspective.
Neurotherapeutics.
11:111-116.
2014
|
|
| 2014
|
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants..
Neurobiology of Aging.
35:266.e5-266.14.
2014
|
|
| 2013
|
A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease
2013
|
|
| 2013
|
Association of parkinson disease with structural and regulatory variants in the hla region.
American Journal of Human Genetics.
93:984-993.
2013
|
|
| 2013
|
Exploratory analysis of seven Alzheimer's disease genes: Disease progression.
Neurobiology of Aging.
34:1310.e1-1310.e7.
2013
|
|
| 2012
|
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study.
Neurology.
78:1434-1440.
2012
|
|
| 2012
|
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDgene database.
PLoS Genetics.
8.
2012
|
|
| 2012
|
Meta-analysis of Parkinson's Disease: Identification of a novel locus, RIT2.
Annals of Neurology.
71:370-384.
2012
|
|
| 2011
|
Evidence for more than one parkinson's Disease-Associated variant within the HLA region.
PLoS One.
6.
2011
|
|
| 2011
|
Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.
Movement Disorders.
26:2190-2195.
2011
|
|
| 2011
|
An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease.
European Journal of Neurology.
18.
2011
|
|
| 2011
|
Genome-wide gene-environment study identifies glutamate receptor gene grin2a as a parkinson's disease modifier gene via interaction with coffee.
PLoS Genetics.
7.
2011
|
|
| 2011
|
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: An exploratory analysis.
Journal of Neurology, Neurosurgery and Psychiatry.
82:564-568.
2011
|
|
| 2010
|
SNCA variant associated with Parkinson disease and plasma α-synuclein level.
JAMA Neurology.
67:1350-1356.
2010
|
|
| 2010
|
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.
Movement Disorders.
25:2156-2163.
2010
|
|
| 2010
|
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
Neurology.
75:1189-1194.
2010
|
|
| 2010
|
The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors.
Journal of Human Genetics.
55:241-243.
2010
|
|
| 2010
|
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease.
Nature Genetics.
42:781.
2010
|
|
| 2010
|
Visualizing disease associations: Graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease.
Genetic Epidemiology.
34:92-99.
2010
|
|
| 2008
|
Genetic association between α-synuclein and idiopathic Parkinson's disease.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
147:1222-1230.
2008
|
|
| 2008
|
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study..
Lancet Neurology.
7:583-590.
2008
|
|
| 2008
|
Exploring gene-environment interactions in Parkinson's disease.
Human Genetics.
123:257-265.
2008
|
|
| 2008
|
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.
Movement Disorders.
23:88-95.
2008
|
|
| 2008
|
Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.
European Journal of Neurology.
15:134-139.
2008
|
|
| 2007
|
DBH -1021C→T does not modify risk or age at onset in Parkinson's disease.
Annals of Neurology.
62:99-101.
2007
|
|
| 2007
|
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Annals of Neurology.
62:137-144.
2007
|
|
| 2007
|
Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients.
Annals of Neurology.
61:47-54.
2007
|
|
| 2007
|
Leucine-rich repeat kinase 1: A paralog of LRRK2 and a candidate gene for Parkinson's disease.
Neurogenetics.
8:95-102.
2007
|
|
| 2006
|
Early-onset Alzheimer disease in families with late-onset alzheimer disease: A potential important subtype of familial Alzheimer disease.
JAMA Neurology.
63:1307-1311.
2006
|
|
| 2006
|
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease.
Genetic Testing and Molecular Biomarkers.
10:221-227.
2006
|
|
| 2006
|
Analysis of the LRRK2 G2019S mutation in Alzheimer disease [3].
JAMA Neurology.
63:156-157.
2006
|
|
| 2006
|
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: Evidence of two distinct founding events beginning two millennia ago.
American Journal of Human Genetics.
79:752-758.
2006
|
|
| 2006
|
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.
Lancet Neurology.
5:917-923.
2006
|
|
| 2006
|
Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics.
Movement Disorders.
21:519-523.
2006
|
|
| 2005
|
One step closer to fixing association studies: Evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls.
Human Genetics.
118:322-330.
2005
|
|
| 2005
|
Erratum: Parkin mutation analysis in clinic patients with early-onset Parkinson's disease (American Journal of Medical Genetics (2004) 129A (44-50) DOI: 10.1002/ajmg.a.30157).
American Journal of Medical Genetics Part A.
139 A:56.
2005
|
|
| 2005
|
Apolipoprotein E ε4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: Relationship to dementia and hallucinations.
Movement Disorders.
20:989-994.
2005
|
|
| 2005
|
Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation [2].
Movement Disorders.
20:1077-1078.
2005
|
|
| 2005
|
False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy [1].
Annals of Neurology.
57:462-463.
2005
|
|
| 2005
|
parkin mutation dosage and the phenomenon of anticipation: A molecular genetic study of familial parkinsonism.
BMC Neurology.
5.
2005
|
|
| 2005
|
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: Evidence of a common founder across European populations.
American Journal of Human Genetics.
76:672-680.
2005
|
|
| 2004
|
parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease..
American Journal of Medical Genetics Part A.
129A:44-50.
2004
|
|
| 2004
|
parkin mutation analysis in clinic patients with early-onset Parkinson's disease.
American Journal of Medical Genetics Part A.
129 A:44-50.
2004
|
|
| 2004
|
Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease.
Neurogenetics.
5:121-128.
2004
|
|
| 2004
|
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Movement Disorders.
19:622-629.
2004
|
|
| 2004
|
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.
American Journal of Human Genetics.
75:398-409.
2004
|
|
| 2003
|
Independent predictors of cognitive decline in the healthy elderly.
Research and practice in Alzheimer's disease.
7:86-92.
2003
|
|
| 2003
|
A linkage study of candidate loci in familial Parkinson's Disease.
BMC Neurology.
3.
2003
|
|
| 2003
|
SCA2 may present as levodopa-responsive parkinsonism.
Movement Disorders.
18:425-429.
2003
|
|
| 2002
|
Onset age of Parkinson disease [9] (multiple letters).
American Journal of Medical Genetics Part A.
111:459-460.
2002
|
|
| 2002
|
Familial aggregation of Parkinson disease: A comparative study of early-onset and late-onset disease.
JAMA Neurology.
59:848-850.
2002
|
|
| 2002
|
HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease.
Neurology.
58:973-975.
2002
|
|
| 2002
|
Age at onset of Parkinson disease and apolipoprotein E genotypes.
American Journal of Medical Genetics Part A.
107:156-161.
2002
|
|
| 2002
|
Accurate determination of ataxin-2 polyglutamine expansion in patients with intermediate-range repeats.
Genetic Testing and Molecular Biomarkers.
6:217-220.
2002
|
|
| 2002
|
Independent predictors of cognitive decline in healthy elderly persons.
JAMA Neurology.
59:601-606.
2002
|
|
| 2001
|
Expression of α-synuclein in the human brain: Relation to Lewy body disease.
Brain Research.
92:58-65.
2001
|
|
| 2001
|
Parkinson's disease, CYP2D6 polymorphism, and age.
Neurology.
56:1363-1370.
2001
|
|
| 2001
|
Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.
JAMA Neurology.
58:383-387.
2001
|
|
| 2001
|
Predictors of healthy brain aging
2001
|
|
| 2000
|
The number of trait loci in late-onset Alzheimer disease.
American Journal of Human Genetics.
66:196-204.
2000
|
|
| 1999
|
Apolipoprotein E ε4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
Dementia and Geriatric Cognitive Disorders.
10:437-441.
1999
|
|
| 1999
|
Exclusion of dominant mutations within the FTDP-17 locus on chromosome 17 for Parkinson's disease.
Neuroscience Letters.
272:140-142.
1999
|
|
| 1999
|
A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
1999
|
|
| 1999
|
Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations.
Neuroscience Letters.
260:193-195.
1999
|
|
| 1999
|
Correction: A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) (Brain (1999) 122, 4 (741-756))
1999
|
|
| 1998
|
Segregation analysis of Parkinson disease.
American Journal of Medical Genetics Part A.
80:410-417.
1998
|
|
| 1998
|
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
1998
|
|
| 1998
|
Analysis of the α-synuclein G209A mutation in familial Parkinson's disease [7]
1998
|
|
| 1998
|
Apolipoprotein E genotypes and age at onset of Parkinson's disease [4] (multiple letters).
Annals of Neurology.
44:294-295.
1998
|
|
| 1998
|
Genetic epidemiology of Parkinson's disease.
Journal of Geriatric Psychiatry and Neurology.
11:98-106.
1998
|
|
| 1997
|
Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.
Annals of Neurology.
42:655-658.
1997
|
|
| 1997
|
A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): Effects of family history and apolipoprotein E genotype.
American Journal of Human Genetics.
60:948-956.
1997
|
|
| 1997
|
Chromosome 17 and hereditary dementia: Linkage studies in three non- Alzheimer families and kindreds with late-onset FAD.
Neurology.
48:949-954.
1997
|
|
| 1997
|
Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.
Journal of the American Geriatrics Society.
45:584-589.
1997
|
|
| 1997
|
Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease.
Neurology.
49:512-518.
1997
|
|
| 1996
|
Gender difference in apolipoprotein E - associated risk for familial alzheimer disease: A possible clue to the higher incidence of alzheimer disease in women.
American Journal of Human Genetics.
58:803-811.
1996
|
|
| 1996
|
Increased risk of familial late-onset Alzheimer's disease in women.
Neurology.
46:126-129.
1996
|
|
| 1996
|
Reply from the Author: Gender and AD.
Neurology.
47:1358.
1996
|
|
| 1995
|
The Apolipoprotein E E4 Allele and Sex-Specific Risk of Alzheimer's Disease-Reply.
Journal of the American Medical Association.
273:374.
1995
|
|
| 1995
|
Genetic anticipation in parkinson's disease.
Neurology.
45:135-138.
1995
|
|
| 1995
|
Increased Risk of Parkinson's Disease in Relatives of Patients.
Annals of Neurology.
37:685-685.
1995
|
|
| 1995
|
No evidence for association of familial parkinson's disease with cag repeat expansion.
Neurology.
45:1760-1763.
1995
|
|
| 1995
|
Reply.
Annals of Neurology.
37:685-685.
1995
|
|
| 1994
|
Alzheimer's Disease, Apolipoprotein E4, and Gender.
Journal of the American Medical Association.
271:1316-1317.
1994
|
|
| 1994
|
Alzheimer's disease, apolipoprotein E4, and gender.
Journal of the American Medical Association.
271:1316-1317.
1994
|
|
| 1994
|
Evidence for familial factors that protect against dementia and outweigh the effect of increasing age.
American Journal of Human Genetics.
54:650-657.
1994
|
|
| 1994
|
The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.
American Journal of Human Genetics.
54:631-642.
1994
|
|
| 1994
|
Genetic factors that protect against dementia [6].
American Journal of Human Genetics.
55:588-589.
1994
|
|
| 1994
|
Increased risk of Parkinson's disease in parents and siblings of patients.
Annals of Neurology.
36:659-661.
1994
|
|
| 1993
|
Apolipoprotein E genotype and Alzheimer's disease
1993
|
|
| 1993
|
Apolipoprotein E genotype and Alzheimer's disease.
1993
|
|
| 1993
|
Chromosome 14 and late-onset familial Alzheimer disease (FAD).
American Journal of Human Genetics.
53:619-628.
1993
|
|
| 1993
|
Lack of evidence for maternal effect in familial Alzheimer's disease.
Genetic Epidemiology.
10:461-464.
1993
|
|
| 1992
|
Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
American Journal of Human Genetics.
51:998-1014.
1992
|
|
| 1991
|
HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic alzheimer’s disease in mene.
Neurology.
41:1544-1548.
1991
|
|
| 1989
|
Disease associations and disequilibrium mapping..
Progress in clinical and biological research.
329:57-62.
1989
|
|
| 1989
|
A simple method to detect and estimate heterogeneity: application to Huntington disease, diabetes, and HIV seroconversion.
American Journal of Human Genetics.
44:107-114.
1989
|
|
| 1989
|
Autoimmune thyroid disease in type I diabetic families.
Genetic Epidemiology.
6:137-141.
1989
|
|
| 1989
|
HLA may be involved in resistance and susceptibility to affective disorders.
Genetic Epidemiology.
6:293-298.
1989
|
|
| 1989
|
Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.
American Journal of Human Genetics.
45:541-546.
1989
|
|
| 1987
|
Analysis of genetic interrelationship among HLA-associated diseases.
American Journal of Human Genetics.
41:331-349.
1987
|
|
| 1987
|
The affected sib method. V. Testing the assumptions.
Annals of Human Genetics.
51:75-92.
1987
|
|
| 1987
|
The affected sib method. V. Testing the assumptions..
Annals of Human Genetics.
51:75-92.
1987
|
|
| 1986
|
A synergistic three allele model for the HLA‐linked components of coeliac disease predisposition.
Genetic Epidemiology.
3:277-282.
1986
|
|
| 1986
|
Family and population analysis of multiple sclerosis.
Genetic Epidemiology.
3:381-386.
1986
|
|
| 1986
|
Genetics of rheumatoid arthritis.
HLA.
27:57-63.
1986
|
|
| 1985
|
The affected sib method. IV. Sib trios..
Annals of Human Genetics.
49:303-314.
1985
|
|
| 1985
|
The affected sib method. IV. Sib trios.
Annals of Human Genetics.
49:303-314.
1985
|
|
| 1984
|
The affected sib method. III. Selection and recombination..
American Journal of Human Genetics.
36:352-362.
1984
|
|
| 1984
|
The affected sib method. III. Selection and recombination.
American Journal of Human Genetics.
36:353-362.
1984
|
|
| 1983
|
The affected sib method. II. The intermediate model..
Annals of Human Genetics.
47:225-243.
1983
|
|
| 1983
|
The affected sib method. II. The intermediate model.
Annals of Human Genetics.
47:225-243.
1983
|
|
